Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1994 2
2006 3
2007 3
2008 2
2009 3
2010 12
2011 14
2012 18
2013 16
2014 20
2015 28
2016 42
2017 41
2018 54
2019 82
2020 113
2021 101
2022 107
2023 91
2024 51

Text availability

Article attribute

Article type

Publication date

Search Results

694 results

Results by year

Filters applied: . Clear all
Page 1
CRISPR/Cas9 for cancer research and therapy.
Zhan T, Rindtorff N, Betge J, Ebert MP, Boutros M. Zhan T, et al. Semin Cancer Biol. 2019 Apr;55:106-119. doi: 10.1016/j.semcancer.2018.04.001. Epub 2018 Apr 16. Semin Cancer Biol. 2019. PMID: 29673923 Free article. Review.
WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis.
Tai P, Chen X, Jia G, Chen G, Gong L, Cheng Y, Li Z, Wang H, Chen A, Zhang G, Zhu Y, Xiao M, Wang Z, Liu Y, Shan D, He D, Li M, Zhan T, Khan A, Li X, Zeng X, Li C, Ouyang D, Ai K, Chen X, Liu D, Liu Z, Wei D, Cao K. Tai P, et al. Among authors: zhan t. J Transl Med. 2023 Nov 17;21(1):823. doi: 10.1186/s12967-023-04715-1. J Transl Med. 2023. PMID: 37978379 Free PMC article.
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial.
Lorenzen S, Götze TO, Thuss-Patience P, Biebl M, Homann N, Schenk M, Lindig U, Heuer V, Kretzschmar A, Goekkurt E, Haag GM, Riera-Knorrenschild J, Bolling C, Hofheinz RD, Zhan T, Angermeier S, Ettrich TJ, Siebenhuener AR, Elshafei M, Bechstein WO, Gaiser T, Loose M, Sookthai D, Kopp C, Pauligk C, Al-Batran SE; AIO and SAKK Study Working Groups. Lorenzen S, et al. Among authors: zhan t. J Clin Oncol. 2024 Feb 1;42(4):410-420. doi: 10.1200/JCO.23.00975. Epub 2023 Nov 14. J Clin Oncol. 2024. PMID: 37963317 Clinical Trial.
The Roles of Secreted Wnt Ligands in Cancer.
Werner J, Boonekamp KE, Zhan T, Boutros M. Werner J, et al. Among authors: zhan t. Int J Mol Sci. 2023 Mar 10;24(6):5349. doi: 10.3390/ijms24065349. Int J Mol Sci. 2023. PMID: 36982422 Free PMC article. Review.
The drug-induced phenotypic landscape of colorectal cancer organoids.
Betge J, Rindtorff N, Sauer J, Rauscher B, Dingert C, Gaitantzi H, Herweck F, Srour-Mhanna K, Miersch T, Valentini E, Boonekamp KE, Hauber V, Gutting T, Frank L, Belle S, Gaiser T, Buchholz I, Jesenofsky R, Härtel N, Zhan T, Fischer B, Breitkopf-Heinlein K, Burgermeister E, Ebert MP, Boutros M. Betge J, et al. Among authors: zhan t. Nat Commun. 2022 Jun 6;13(1):3135. doi: 10.1038/s41467-022-30722-9. Nat Commun. 2022. PMID: 35668108 Free PMC article.
Analyzing longitudinal binary data in clinical studies.
Li Y, Feng D, Sui Y, Li H, Song Y, Zhan T, Cicconetti G, Jin M, Wang H, Chan I, Wang X. Li Y, et al. Among authors: zhan t. Contemp Clin Trials. 2022 Apr;115:106717. doi: 10.1016/j.cct.2022.106717. Epub 2022 Feb 28. Contemp Clin Trials. 2022. PMID: 35240309 Review.
Cross-Talk between p53 and Wnt Signaling in Cancer.
Xiao Q, Werner J, Venkatachalam N, Boonekamp KE, Ebert MP, Zhan T. Xiao Q, et al. Among authors: zhan t. Biomolecules. 2022 Mar 15;12(3):453. doi: 10.3390/biom12030453. Biomolecules. 2022. PMID: 35327645 Free PMC article. Review.
694 results